Laporan Laba Rugi 002788 - TTM - Luyan Pharma Co.,Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Luyan Pharma Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2023 01-01	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	15,284	15,535	16,340	16,795	17,135	17,545	18,017	18,412	18,866	19,462	19,667	20,146	19,914	19,846	20,140	20,127	20,484	20,471	20,509	20,565
Change (%)		1.64	5.18	2.78	2.02	2.40	2.69	2.19	2.47	3.16	1.05	2.44	-1.15	-0.34	1.48	-0.06	1.77	-0.06	0.19	0.27
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	14,070	14,308	15,057	15,492	15,812	16,179	16,628	16,983	17,416	17,950	18,132	18,609	18,399	18,339	18,617	18,589	18,932	18,948	19,002	19,076
Change (%)		1.69	5.24	2.89	2.06	2.33	2.77	2.14	2.55	3.07	1.01	2.63	-1.13	-0.32	1.52	-0.15	1.85	0.09	0.29	0.39
% of Revenue	92.06	92.10	92.15	92.24	92.28	92.21	92.29	92.24	92.31	92.23	92.20	92.37	92.39	92.41	92.44	92.36	92.42	92.56	92.65	92.76

Gross Operating Profit	1,214	1,227	1,283	1,303	1,323	1,366	1,389	1,429	1,451	1,512	1,535	1,537	1,515	1,506	1,522	1,539	1,552	1,523	1,507	1,489
Change (%)		1.07	4.53	1.59	1.54	3.24	1.68	2.85	1.54	4.24	1.50	0.13	-1.41	-0.57	1.05	1.08	0.86	-1.89	-1.06	-1.20
% of Revenue	7.94	7.90	7.85	7.76	7.72	7.79	7.71	7.76	7.69	7.77	7.80	7.63	7.61	7.59	7.56	7.64	7.58	7.44	7.35	7.24

SG&A	629	636	667	676	703	725	729	753	750	764	777	777	780	764	776	779	792	786	784	793
Change (%)		1.07	4.86	1.41	3.93	3.11	0.61	3.25	-0.36	1.83	1.76	0.01	0.27	-2.01	1.62	0.40	1.58	-0.77	-0.15	1.15
% of Revenue	4.12	4.09	4.08	4.03	4.10	4.13	4.05	4.09	3.98	3.93	3.95	3.86	3.91	3.85	3.85	3.87	3.87	3.84	3.83	3.86

R&D	5	4	4	4	3	3	3	3	4	4	4	5	4	6	6	6	6	6	6	6
Change (%)		-18.79	-5.97	3.71	-9.76	-10.46	-1.31	-7.79	30.87	17.14	4.01	8.61	-11.95	34.18	8.11	5.87	0.01	-7.71	2.53	-0.84
% of Revenue	0.03	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03

OpEx	14,731	14,985	15,768	16,216	16,564	16,945	17,399	17,778	18,209	18,760	18,954	19,429	19,221	19,151	19,444	19,420	19,773	19,787	19,840	19,931
Change (%)		1.72	5.23	2.84	2.15	2.30	2.68	2.18	2.42	3.03	1.03	2.51	-1.07	-0.37	1.53	-0.13	1.82	0.07	0.27	0.46
% of Revenue	96.38	96.46	96.50	96.55	96.67	96.58	96.57	96.56	96.52	96.39	96.38	96.44	96.52	96.50	96.55	96.48	96.53	96.66	96.74	96.92

Operating Income	553	550	572	579	571	600	618	634	657	702	713	716	693	695	695	707	711	684	669	634
Change (%)		-0.47	3.90	1.28	-1.39	5.16	2.93	2.54	3.76	6.83	1.46	0.53	-3.28	0.28	0.07	1.74	0.48	-3.74	-2.28	-5.25
% of Revenue	3.62	3.54	3.50	3.45	3.33	3.42	3.43	3.44	3.48	3.61	3.62	3.56	3.48	3.50	3.45	3.52	3.47	3.34	3.26	3.08

Interest Expense	-168	-164	-166	-166	-171	-190	-191	-207	-206	-219	-223	-222	-221	-223	-223	-217	-226	-207	-204	-198
Change (%)		-2.24	1.04	0.10	2.91	11.53	0.57	8.31	-0.64	6.39	1.86	-0.67	-0.43	0.97	-0.11	-2.47	4.00	-8.46	-1.35	-2.64
% of Revenue	-1.10	-1.06	-1.01	-0.99	-1.00	-1.08	-1.06	-1.13	-1.09	-1.13	-1.13	-1.10	-1.11	-1.12	-1.11	-1.08	-1.10	-1.01	-0.99	-0.97

Net Income	272	267	280	290	286	306	313	322	325	345	353	365	356	364	367	365	359	346	333	310
Change (%)		-2.05	5.01	3.41	-1.13	6.85	2.33	2.78	0.89	6.35	2.36	3.42	-2.50	2.04	1.08	-0.70	-1.64	-3.69	-3.60	-7.02
% of Revenue	1.78	1.72	1.71	1.72	1.67	1.74	1.74	1.75	1.72	1.77	1.80	1.81	1.79	1.83	1.82	1.81	1.75	1.69	1.62	1.51

Source: Capital IQ

Luyan Pharma Co.,Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)